Latest Supply Agreements News

Sea Forest Limited launches a $20.5 million IPO on the ASX to scale production and commercialisation of SeaFeed™, a scientifically validated livestock feed additive that cuts methane emissions by up to 80% while boosting productivity.

Cobalt Blue Holdings has significantly upgraded the economics of its Kwinana Cobalt Refinery project, driven by a sharp rebound in cobalt prices following market disruptions in the Democratic Republic of Congo. The company is advancing towards a Final Investment Decision with key permits and supply agreements in place.

OMG Group has secured its maiden purchase order for premium SANDAI matcha in Australia, marking a promising start to a new high-margin revenue channel ahead of FY26.

Saferoads Holdings has divested its Road Safety Rentals business for $10.8 million, repaid debt, and is now focusing on rebuilding its core product sales with new hires and product innovation.

OMG Group has inked a five-year exclusive distribution agreement with SANDAI, a premium Japanese matcha producer, positioning itself to capture significant growth in Australia’s expanding matcha market.

Vintage Energy has signed a conditional agreement to acquire Metgasco's 25% interest in key Southern Flank gas joint ventures, aiming to accelerate production and value creation from the Vali and Odin fields.

Metgasco Ltd has entered a conditional agreement to sell its 25% stake in two gas fields in the Cooper Eromanga Basin to Vintage Energy for $5.9 million, marking a significant shift in its asset portfolio.

Metgasco has agreed to sell its 25% stake in key Cooper Eromanga Basin gas fields to Vintage Energy for $5.9 million, marking a significant shift in its business focus. The deal hinges on Vintage securing funding and acquiring additional interests, with shareholder approval required.

Clover Corporation Limited reported a standout FY25 with robust revenue growth and a sharp rise in profitability, underpinned by strategic market expansion and product innovation. The company’s strengthened balance sheet and optimistic FY26 outlook signal continued momentum.

BlueScope confirms its first-half FY2026 earnings guidance at the lower end of expectations, highlighting a mix of regional challenges and growth initiatives as it navigates cost pressures and market shifts.

Radiopharm Theranostics has secured ethics approval to begin a Phase 1 clinical trial of RAD 402, a pioneering radiotherapeutic targeting advanced prostate cancer using terbium-161. This marks a significant step in developing a potentially safer, more effective treatment option.

Coronado Global Resources posted a $109.5 million net loss for Q3 2025 amid subdued metallurgical coal markets and announced a proposed refinancing deal with Stanwell Corporation to strengthen its financial position.